123 related articles for article (PubMed ID: 4044343)
21. Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary.
Peters WA; Smith MR; Cain JM; Lee RB; Yon JL
Gynecol Oncol; 1992 Nov; 47(2):146-9. PubMed ID: 1468691
[TBL] [Abstract][Full Text] [Related]
22. Update on the role of radiotherapy in ovarian cancer.
Lanciano R; Reddy S; Corn B; Randall M
Semin Oncol; 1998 Jun; 25(3):361-71. PubMed ID: 9633849
[No Abstract] [Full Text] [Related]
23. CA-125 levels after surgical exploration and radioactive chromic phosphate in ovarian cancer patients.
Makhija S; Spanos WJ; Day TG; Doering D
Gynecol Oncol; 1996 Oct; 63(1):85-8. PubMed ID: 8898174
[TBL] [Abstract][Full Text] [Related]
24. The measurement of radiation doses from P32 chromic phosphate therapy of the peritoneum using SPECT.
Ott RJ; Flower MA; Jones A; McCready VR
Eur J Nucl Med; 1985; 11(8):305-8. PubMed ID: 3878292
[TBL] [Abstract][Full Text] [Related]
25. Dose estimation to the infant from breast milk following intraperitoneal administration of chromic phosphate 32P for the treatment of early ovarian cancer.
Sharma SC; Osborne RP; Jose B; Carlson JA
Health Phys; 1984 Sep; 47(3):452-4. PubMed ID: 6500947
[No Abstract] [Full Text] [Related]
26. Intraperitoneal distribution imaging prior to chromic phosphate (P-32) therapy in ovarian cancer patients.
Tulchinsky M; Eggli DF
Clin Nucl Med; 1994 Jan; 19(1):43-8. PubMed ID: 8137583
[TBL] [Abstract][Full Text] [Related]
27. Radioactivity in breast milk after intraperitoneal chromic phosphate for the treatment of early ovarian cancer.
Carlson JA; Jose B; Sharma SC; Osborne RP
Am J Obstet Gynecol; 1983 Dec; 147(7):840-1. PubMed ID: 6650612
[No Abstract] [Full Text] [Related]
28. Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.
Soper JT; Berchuck A; Dodge R; Clarke-Pearson DL
Obstet Gynecol; 1992 Jun; 79(6):993-7. PubMed ID: 1579329
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.
Creasman WT; Disaia PJ; Blessing J; Wilkinson RH; Johnston W; Weed JC
Am J Obstet Gynecol; 1981 Dec; 141(8):921-9. PubMed ID: 7315922
[TBL] [Abstract][Full Text] [Related]
30. Peritoneoscintigraphy in detection of improper placement of peritoneal catheter into bowel lumen prior to chromic phosphate P-32 therapy. A case report.
Neutze J; Van Nostrand D; Major W
Clin Nucl Med; 1985 Nov; 10(11):777-9. PubMed ID: 4075668
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.
Young RC; Brady MF; Nieberg RK; Long HJ; Mayer AR; Lentz SS; Hurteau J; Alberts DS
J Clin Oncol; 2003 Dec; 21(23):4350-5. PubMed ID: 14645424
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant internal hepatic radiotherapy using colloidal 32P chromic phosphate in colorectal cancer.
Kim JY; Bom HS; Kim YJ; Choi W
Radiat Med; 1990; 8(6):246-9. PubMed ID: 2093946
[TBL] [Abstract][Full Text] [Related]
33. [Synoviorthesis of the knee joint with 32P-chromic phosphate (author's transl)].
Galeazzi H; Rösler H; Ramel P; Carnes H
Nuklearmedizin; 1979 Dec; 18(5):223-5. PubMed ID: 547247
[TBL] [Abstract][Full Text] [Related]
34. Experiences with radioactive chromic phosphate in urological tumors.
MOORE V; GAMBLE D; LIBBY RL
AMA Arch Surg; 1956 Mar; 72(3):464-8. PubMed ID: 13291972
[No Abstract] [Full Text] [Related]
35. Synoviorthesis with 32P-colloidal chromic phosphate in rheumatoid arthritis--clinical, histopathologic and arthrographic changes.
Onetti CM; Gutiérrez E; Hliba E; Aguirre CR
J Rheumatol; 1982; 9(2):229-38. PubMed ID: 7097682
[TBL] [Abstract][Full Text] [Related]
36. Bowel perforation associated with intraperitoneal chromic phosphate instillation.
Proctor J; Doering D; Barnhill D; Park R
Gynecol Oncol; 1990 Jan; 36(1):125-7. PubMed ID: 2295443
[TBL] [Abstract][Full Text] [Related]
37. Radio-active colloidal chromic phosphate in the treatment of carcinoma of the urinary bladder.
CANOY NR
J Philipp Med Assoc; 1957 Jun; 33(6):481-6. PubMed ID: 13449721
[No Abstract] [Full Text] [Related]
38. [Histological data on a bladder epithelioma treated by radiophosphorus-labeled colloidal chromic phosphate].
BLUM E; FRUHLING L; BURG C; CHEVALLIER A
Bull Assoc Fr Etud Cancer; 1955; 42(3):299-307. PubMed ID: 13260777
[No Abstract] [Full Text] [Related]
39. Observations on the intraperitoneal distribution of chromic phosphate (32P) suspension for intraperitoneal therapy.
Sullivan DC; Harris CC; Currie JL; Wilkinson RH; Creasman WT
Radiology; 1983 Feb; 146(2):539-41. PubMed ID: 6849103
[TBL] [Abstract][Full Text] [Related]
40. Intraperitoneal chromic phosphate in peritoneoscopically confirmed stage I ovarian adenocarcinoma.
Piver MS; Barlow JJ; Lele SB; Bakshi S; Parthasarathy KL; Bender MA
Am J Obstet Gynecol; 1982 Dec; 144(7):836-40. PubMed ID: 6216811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
